Continued high risk of stroke in treated hypertensives in a general population: The Jichi medical school cohort study

Hypertension Research

Volumn 31, Issue 6, 2008, Pages 1125-1133

  Ishikawa, Shizukiyo ^a   Kario, Kazuomi ^a   Kayaba, Kazunori ^b   Gotoh, Tadao ^a   Nago, Naoki ^c   Nakamura, Yosikazu ^a   Tsutsumi, Akizumi ^d   Kajii, Eiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b SAITAMA PREFECTURAL UNIVERSITY   (Japan)

^c Japanese Association for Integrative Medicine   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Cohort study; Hypertension; Risk factor; Stroke; Treatment

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SUBARACHNOID HEMORRHAGE; SYSTOLIC BLOOD PRESSURE;

AGED; COHORT STUDIES; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; MALE; MIDDLE AGED; RISK; STROKE;

EID: 48349125823     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1125     Document Type: Article

References (44)

1. Lawes CM, Bennett DA, Feigin VI, Rodgers A: Blood pressure and stroke: an overview of published reviews. Stroke 2004; 35: 1024.
2. MacMahon S. Peto R, Cutler J, et al: Blood pressure, stroke, and coronary heart disease. part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
3. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000-people in 45 prospectives cohorts. Prospectives studies collaboration. Lancet 1995; 346: 1647-1653.
4. Blood, pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Lancet 1998; 352: 1001-1807.
5. Lewington S, Clarke R, Qizilbash, N, peto V, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
6. Lawes CM, Rodgers A, Bennett DA, et al: Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21: 707-716.
7. Burt V, Whelton P, Roccella E, et al: Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hyperrension 1995; 25: 305-313.
8. Hozawa A, Ohkubo T, Kikuya M, et al: Blood pressure control assessed by home, ambulatory and conventional blood pressure measurements in the Japanese general population: the Ohasama study. Hypertens Res 2002; 25: 57-63.
9. Cifkova R, Skodova Z, Lanska V, et al: Prevalence, awareness, treatment and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study. J Hum Hypertens 2064; 18, 571-579.
10. Wang Z, Wu Y. Zhao L, Li Y, Yang J, Zhou B: Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population at China, 1992-1998. Hypertens Res 2004; 27: 703-709.
11. Wolf-Maier K, Cooper RS, Kramer H, et al: Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10-17.
12. Ohkubo T, Obara T, Funahashi J, et al: Control of blood pressure as measured at home and office, and comparison with physicians' assessment of control among treated hypertensive patients in Japan: First Report of the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Hypertens Res 2004; 27; 755-763.
13. Ishikawa J, Kario K, Hoshide S, et al: Determinants of exaggerated difference in morning and evening blood pressure measured by self-measured blood pressure monitoring in medicated hypertensive patients: Jichi Morning Hypertension Research (J-MORE) Study. Am J Hypertens 2005; 18: 958-965.
14. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317: 703-713.
15. Almgren T, Persson B, Wilhelmsen L, Rosengren A, Andersson OK: Stroke and coronary heart disease in treated hypertension - a prospective cohort study over three decades. J Intern Med 2005; 257: 496-502.
16. Li C, Engstrom G, Hedblad B, Janzon L: Sex-specific cardiovascular morbidity and mortality in a cohort treated for hypertension. J Hypertens 2006; 24: 1523-1529.
17. Ishikawa S, Shibano Y, Asai Y, Kario K, Kayaba K, Kajii E: Blood pressure categories and cardiovascular risk factors in Japan: the Jichi Medical School (JMS) Cohort Study. Hypertens Res 2007; 30: 643-650.
18. Nago N, Kayaba K, Hiraoka J, et al: Lipoprotein(a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors. The Jichi Medical School Cohort Study. Am J Epidemiol 1995; 141: 815-821.
19. Ishikawa S, Gotoh T, Nago N, Kayaba K: The Jichi Medical School (JMS) Cohort Study: design, baseline data and standardized mortality ratios. J Epidemiol 2002; 12: 408-417.
20. Japanese Society of Hypertension: Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). Hypertens Res 2006; 29: S1-S105.
21. Adams HP Jr, Bendixen BH, Kappelle LJ, et al: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
22. Sudlow CL, Warlow CP: Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 1997; 28: 491-499.
23. Stegmayr B, Asplund K, Kuulasmaa K, Rajakangas AM, Thorvaldsen P, Tuomilehto J: Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations. Stroke 1997; 28: 1367-1374.
24. Kubo M, Kiyohara Y, Kato I, et al: Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003; 34: 2349-2354.
25. Carandang R, Seshadri S, Beiser A, et al: Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 2006; 296: 2939-2946.
26. Shimamoto T, Komachi Y, Inada H, et al: Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989; 79: 503-515.
27. Kodama K: Stroke trends in Japan. Ann Epidemiol 1993; 3: 524-528.
28. Shinkawa A, Ueda K, Kiyohara Y, et al: Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. Stroke 1995; 26: 380-385.
29. Du X, Cruickshank K, McNamee R, et al: Case-control study of stroke and the quality of hypertension control in north west England. BMJ 1997; 314: 272-276.
30. Klungel O, Kaplan R, Heckbert S, et al: Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients. Stroke 2000; 31: 420-424.
31. Makino Y, Kawano Y, Minami J, Yamaguchi T, Takishita S: Risk of stroke in relation to level of blood pressure and other risk factors in treated hypertensive patients. Stroke 2000; 31: 48-52.
32. Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L: Survival in treated hypertension: follow up study after two decades. BMJ 1998; 317: 167-171.
33. Harmsen P, Lappas G, Rosengren A, Wilhelmsen L: Longterm risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in Göteborg, Sweden. Stroke 2006; 37: 1663-1667.
34. Fagard RH, Staessen JA, Thijs L, et al: Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Circulation 2000; 102: 1139-1144.
35. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265: 3255-3264.
36. Staessen JA, Fagard R, Thijs L, et al: Randomised doubleblind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-764.
37. Hu G: Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 2003; 46: 608-617.
38. Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J: Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia 2005; 48: 856-861.
39. Gueyffier F, Boutitie F, Boissel J, et al: Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The DANA Investigators. Ann Intern Med 1997; 126: 761-767.
40. Wilson PW, Cupples LA, Kannel WB: Is hyperglycemia associated with cardiovascular disease? The Framingham Study. Am Heart J 1991; 121: 586-590.
41. de Vegt F, Dekker JM, Ruhe HG, et al: Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 1999; 42: 926-931.
42. Giorda CB, Avogaro, A, Maggini M, et al: Incidence and risk factors for stroke in type 2 diabetic patients: the DAI Study. Stroke 2007; 38: 1154-1160.
43. Asia Pacific Cohort Studies Collaboration: Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia-Pacific region. J Hypertens 2007; 25: 1205-1213.
44. Almgren T, Wilhelmsen L, Samuelsson O, Himmelmann A, Rosengren A, Andersson OK: Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up. J Hypertens 2007; 25: 1311-1317.